glp-1 and stroke Risk of major adverse cardiovascular events associated with treatment with or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis Why Hong Kong scientists think

Angew Chem Int Ed Eng 55:1247512478 Mauvais-Jarvis F (2011) Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity

Song YS, Lee HJ, Park IH, Kim WK, Ku JH, Kim SU

In contrast, GLP-/GIP dual agonists, while controlling blood sugar, can more comprehensively regulate lipid metabolism and reduce the risk of cardiovascular diseases [138,139]

This can lead to Sleep Deprivation and reduced Hypothalamus, Pituitary & Adrenal Glands Axis (HPAA) Signaling, further increasing Serum Cortisol Levels, which send a Negative Feedback to the Testicles, lowering Testosterone Production

Lilly has not announced US pricing